1. Search Result

Search Result

Targets Recommended: CRISPR/Cas9

Results for "1071517-39-9" in MCE Product Catalog:

Cat. No. Product Name Target Research Area
  • HY-13247


    DNA/RNA Synthesis HCV SARS-CoV Infection
    Setrobuvir (ANA598) is an orally active non-nucleosidic HCV NS5B polymerase inhibitor. ANA-598 inhibits both de novo RNA synthesis and primer extension, with IC50s between 4 and 5 nM. Setrobuvir also shows excellent binding affinity to SARS-CoV-2 RdRp and induces RdRp inhibition.